blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2408431

EP2408431 - SOLID RETIGABINE IN NON-CRYSTALLINE FORM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.06.2014
Database last updated on 15.06.2024
Most recent event   Tooltip20.06.2014Application deemed to be withdrawnpublished on 23.07.2014  [2014/30]
Applicant(s)For all designated states
ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
[N/P]
Former [2012/04]For all designated states
Ratiopharm GmbH
Graf-Arco-Strasse 3
89070 Ulm / DE
Inventor(s)01 / RIMKUS, Katrin
Gaimeistrasse 23
586363 Iserlohn / DE
02 / PÄTZ, Jana
Muffendorfer Hauptstrasse 28
53177 Bonn / DE
 [2012/04]
Representative(s)Aechter, Bernd
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Mauerkircherstrasse 45
81679 München / DE
[N/P]
Former [2012/04]Aechter, Bernd
Ter Meer Steinmeister & Partner GbR Mauerkircherstrasse 45
81679 München / DE
Application number, filing date10709698.417.03.2010
WO2010EP01691
Priority number, dateDE2009101361117.03.2009         Original published format: DE102009013611
[2012/04]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2010105823
Date:23.09.2010
Language:DE
[2010/38]
Type: A1 Application with search report 
No.:EP2408431
Date:25.01.2012
Language:DE
The application published by WIPO in one of the EPO official languages on 23.09.2010 takes the place of the publication of the European patent application.
[2012/04]
Search report(s)International search report - published on:EP23.09.2010
ClassificationIPC:A61K9/16, A61K9/19, A61K31/167
[2012/04]
CPC:
A61K31/167 (EP,US); A61K31/27 (EP,US); A61K9/146 (EP,US);
A61K9/1623 (EP,US); A61K9/1635 (EP,US); A61K9/1641 (EP,US);
A61K9/1652 (EP,US); A61K9/1676 (EP,US); A61K9/19 (EP,US);
A61K9/2054 (EP,US); A61K9/2077 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/04]
TitleGerman:FESTES RETIGABIN IN NICHT-KRISTALLINER FORM[2012/04]
English:SOLID RETIGABINE IN NON-CRYSTALLINE FORM[2012/04]
French:RÉTIGABINE SOLIDE SOUS FORME NON CRISTALLINE[2012/04]
Entry into regional phase27.09.2011National basic fee paid 
27.09.2011Designation fee(s) paid 
27.09.2011Examination fee paid 
Examination procedure27.09.2011Examination requested  [2012/04]
04.05.2012Amendment by applicant (claims and/or description)
29.07.2013Despatch of a communication from the examining division (Time limit: M06)
11.02.2014Application deemed to be withdrawn, date of legal effect  [2014/30]
07.03.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/30]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.07.2013
Fees paidRenewal fee
23.03.2012Renewal fee patent year 03
26.03.2013Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.201405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]WO0166081  (AWD PHARMA GMBH & CO KG [DE]) [XD] 1-3,7,12,14-18,20 * examples 15-24 *;
 [IDY]WO9831663  (ASTA MEDICA AG [DE]) [ID] 19,20 * Seite 3, Zeile 14 - Seite 4, Zeile 20 * [Y] 1-18;
 [Y]US2007116729  (PALEPU NAGESWARA R [US]) [Y] 1-18 * [0025], [0026], [0031], [0053] *;
 [XP]WO2009118167  (RATIOPHARM GMBH [DE], et al) [XP] 1-5,8,9,12,14,15,18,20 * Seite 3, Zeile 7-15; Seite 7, Zeile 5; Seite 8, Zeile 20-21; Seite 12, Zeile 28 - Seite 13, Zeile 10 *;
 [XP]WO2009149955  (RATIOPHARM GMBH [DE], et al) [XP] 1-5,8,9,12,14,15,18,20 * Seite 11, Zeile 10; Seite 12, Zeile 19-20; Seite 13, Zeile 4-5 und 17-22; Seite 18, Zeile 3-5 *
 [A]  - MARSAC PATRICK J ET AL, "Estimation of Drug-Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters", PHARMACEUTICAL RESEARCH (DORDRECHT), (200901), vol. 26, no. 1, ISSN 0724-8741, pages 139 - 151, XP002580850 [A] 1-18 * Seite 139-140, Absatz "Introduction" *

DOI:   http://dx.doi.org/10.1007/S11095-008-9721-1
by applicantEP0554543
 WO0122953
 WO02080898
 WO0166081
 WO9831663
 EP0956281
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.